Who can apply?
Principle Investigators should apply for fellowship funding to support clinical (Grade E64) or basic research scientists (Grade 7/8) committed to translational science and interested in obtaining experience with drug development in an industrial setting.
Fellowship applications may include a named fellow, but this is not mandatory. It is expected that a suitable fellowship candidate will be identified by the Principle Investigator within 6 months of notification of successful project selection.
New for 2022: Principle Investigators can have a maximum of 2 Oxford-BMS Fellowships running at any one time (though you can be a co-investigator on other fellowships if you are already lead investigator on 2 projects).
The proposed fellowship needs to align with BMS’s fields of interest as listed below:
1. Novel targets, biomarkers, cellular therapeutic approaches, or translational models in one of the following areas:
- solid tumour targets including drug resistance
- neurodegenerative and neuroinflammatory diseases including Alzheimer’s, Parkinson’s, ALS, FTD and MS;
- fibrosing disorders including IPF, scleroderma, and Renal Fibrosis;
- rheumatic and dermatologic disorders including RA, SLE, spondyloarthropathies, psoriasis and atopic dermatitis;
- hematologic disorders including AML, Myeloma, DLBCL;
- chronic heart failure (either with preserved or reduced ejection fraction).
2. Methods for evaluating biochemical, cellular, tissue and phenotypic consequences of modulating epigenetic targets.
3. Methods for immuno-phenotyping of human subjects in oncology and autoimmunity
4. Novel imaging approaches to measuring disease activity in the above areas.